Topic Reading-Vol.2530-3/16/2019
0422-27-5366
〒180-0006 東京都武蔵野市中町2-3-5 IIHA武蔵野1階
電話受付/月〜金 9:00-18:00
Topic Reading-Vol.2530-3/16/2019
0422-27-5366
〒180-0006 東京都武蔵野市中町2-3-5 IIHA武蔵野1階
電話受付/月〜金 9:00-18:00
Topic Reading-Vol.2530-3/16/2019
Dear MEL Topic Readers,
Who is making money from your DNA?
Data monopoly doesn’t seem to be limited only to GAFA, Google, Amazon, Facebook, and Apple, or BAT, Baidu, Alibaba, and Tencent, at least for now. There are companies that are collecting and sharing DNA data from their customers who provide their DNA samples for diagnoses. Such diagnosis service providers not only make money by selling DNA analysis to their customers but also by sharing the data with or selling them to pharmaceutical companies like GSK, who try to develop more effective medicine or treatment faster at less cost.
That sounds like a decent business model because it could reduce the cost for both diagnosis and medicine. However, are those customers well aware of the fact that their DNA samples are used for other purposes by third parties? Also, are the data gathered by such method valid to develop medicine for anyone because the availability and affordability of such DNA diagnosis services are still limited to affluent, educated people who live in a small number of developed countries.
As the era of medical big data is on the horizon, it is a question of who should obtain, retain, and benefit from DNA sample data. Should it be private enterprises or public services?
Enjoy reading and learn what DNA samples could do to businesses and medical services.
http://www.bbc.com/capital/story/20190301-how-screening-companies-are-monetising-your-dna
電話：0422-27-5366
住所 〒181-0013 東京都三鷹市下連雀3-33-13 三鷹第二ビル101
営業時間：電話受付13時～18時 定休日：日曜日